Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41577-020-00460-4

http://scihub22266oqcxt.onion/10.1038/s41577-020-00460-4
suck pdf from google scholar
33024281!7537578!33024281
unlimited free pdf from europmc33024281    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33024281      Nat+Rev+Immunol 2020 ; 20 (11): 709-713
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Cross-reactive memory T cells and herd immunity to SARS-CoV-2 #MMPMID33024281
  • Lipsitch M; Grad YH; Sette A; Crotty S
  • Nat Rev Immunol 2020[Nov]; 20 (11): 709-713 PMID33024281show ga
  • Immunity is a multifaceted phenomenon. For T cell-mediated memory responses to SARS-CoV-2, it is relevant to consider their impact both on COVID-19 disease severity and on viral spread in a population. Here, we reflect on the immunological and epidemiological aspects and implications of pre-existing cross-reactive immune memory to SARS-CoV-2, which largely originates from previous exposure to circulating common cold coronaviruses. We propose four immunological scenarios for the impact of cross-reactive CD4(+) memory T cells on COVID-19 severity and viral transmission. For each scenario, we discuss its implications for the dynamics of herd immunity and on projections of the global impact of SARS-CoV-2 on the human population, and assess its plausibility. In sum, we argue that key potential impacts of cross-reactive T cell memory are already incorporated into epidemiological models based on data of transmission dynamics, particularly with regard to their implications for herd immunity. The implications of immunological processes on other aspects of SARS-CoV-2 epidemiology are worthy of future study.
  • |Adaptive Immunity/drug effects[MESH]
  • |Antibodies, Viral/*biosynthesis[MESH]
  • |Betacoronavirus/drug effects/*immunology/pathogenicity[MESH]
  • |CD4-Positive T-Lymphocytes/drug effects/immunology/virology[MESH]
  • |COVID-19[MESH]
  • |COVID-19 Vaccines[MESH]
  • |Coronaviridae Infections/epidemiology/immunology/*prevention & control/virology[MESH]
  • |Coronaviridae/drug effects/immunology[MESH]
  • |Coronavirus Infections/epidemiology/immunology/*prevention & control/virology[MESH]
  • |Cross Reactions[MESH]
  • |Humans[MESH]
  • |Immunity, Herd/drug effects[MESH]
  • |Immunologic Memory[MESH]
  • |Pandemics/*prevention & control[MESH]
  • |Pneumonia, Viral/epidemiology/immunology/*prevention & control/virology[MESH]
  • |Rhinovirus/drug effects/immunology[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box